Market Pulse
Structured intelligence on corporate strategy, market moves, and industry signals.
Each entry is a briefing, not a headline: event summary, strategic context, and what to watch next.
A Company Pulse is our reading of what a company says in its own press release, with the questions we would want answered. It is not verified reporting and it is not an endorsement. Pulses are made from press releases we collect from several sources, including Wire. Nobody can pay for a Pulse.
Halper Sadeh LLC is investigating Lantheus Holdings' $102.50 per share sale to Curium US Holdings, including potential $12.00 per share in Contingent Value Rights.
Read full analysis →
Halper Sadeh LLC is investigating the sale of Supernus Pharmaceuticals to Indivior Pharmaceuticals for 1.5401 Indivior shares per Supernus share.
Read full analysis →
Halper Sadeh LLC is investigating Bowhead Specialty Holdings Inc.'s $34 per share sale to American Family Mutual Insurance Company, S.I.
Read full analysis →
Halper Sadeh LLC is investigating Sanara MedTech's $33.00 cash and 0.4735 MiMedx share per Sanara share acquisition deal.
Read full analysis →
Halper Sadeh LLC is investigating BioLife Solutions' $11.25 per share cash and 0.1442 Repligen stock sale to Repligen Corporation.
Read full analysis →
Takeda received FDA approval for MIMRYLO (rusfertide) on August 28, 2026, for treating erythrocytosis in adults with polycythemia vera (PV).
Read full analysis →
20/20 BioLabs rescheduled its investor webinar to 2:00 p.m. ET on September 2, 2026, to discuss Q2 2026 results and commercial expansion.
Read full analysis →
Trinity Biotech appointed Jordi Romero as Head of Commercial Operations – Europe to drive profitable growth in diagnostics.
Read full analysis →
NIKE plans to release fiscal 2027 Q1 earnings on October 1, 2026, at 1:15 p.m. PT.
Read full analysis →
A fatality occurred at B2Gold's Masbate Gold Project in the Philippines on August 28, 2026, during scheduled maintenance at the Water Treatment Plant.
Read full analysis →
Oragenics has dosed nine participants in its Phase IIa trial for mTBI treatment ONP-002 across three Australian clinical sites.
Read full analysis →
Mint Inc closed a $2.5M registered direct offering, issuing 1.4M Class A shares at $1.00 each and 1.1M pre-funded warrants.
Read full analysis →
NurExone Biologic Inc. will present at the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference on September 9, 2026.
Read full analysis →
Admiral Markets AS completed restructuring in H1 2026, exiting direct client servicing and becoming an intra-group liquidity provider for Admirals Group.
Read full analysis →
Dr. Phone Fix extends non-brokered convertible debenture financing deadline to September 30, 2026, with $1.6M raised so far in two tranches.
Read full analysis →
Inturai Ventures closed the first tranche of its private placement, raising $941K by issuing 6.27M units at $0.15 per unit.
Read full analysis →
CSC seized contraband worth $143,510 at Drumheller Institution on August 19 and 26, 2026.
Read full analysis →
IDrive Inc. launched IDrive Autonomy Assisted Driving, a licenseable L2+ driver-assistance platform on August 28, 2026.
Read full analysis →
Hoymiles showcased expanded PV and energy storage solutions at Intersolar South America 2026, marking a decade in Brazil.
Read full analysis →
Fortinet has signed a multi-year sponsorship deal with Stanford Athletics, beginning with the 2026–27 academic year.
Read full analysis →
